Christophe Segalini

Christophe Segalini has extensive experience in the pharmaceutical industry, having held various senior leadership roles throughout their career. Christophe started their career at Roussel-UCLAF, where they served as the General Manager for Uruguay and Paraguay before transitioning to roles as the Sales & Marketing Director in Argentina and the International Market Research Head.

Afterwards, Segalini joined Abbott as the Hospital Business Unit Director in Brazil. Christophe then moved to Bristol-Myers Squibb, where they held multiple executive positions, including Executive Director of Global Marketing Access for Immunology, Oncology, and Virology, and Executive Director of US Market Access Strategy. At AstraZeneca, they served as the Executive Director of US Diabetes Market Access Strategy.

Segalini's most recent positions include Head of Global Market Access & Pricing at Gilead Sciences and Senior Vice President and Head of Global Value & Access at Idorsia Pharmaceuticals Ltd. Overall, they have demonstrated strong expertise in market access strategy, pricing, and commercialization across various geographic regions.

Christophe Segalini holds an MBA from Northwestern University - Kellogg School of Management. Christophe also has a Doctorate in Pharmacy from the University of Lille. Additionally, they obtained a Master's degree in Marketing & Strategy from Université Paris Dauphine - PSL.